Pds biotechnology announces conference call and webcast for first quarter 2023 financial results

Florham park, n.j., may 04, 2023 (globe newswire) -- pds biotechnology corporation (nasdaq: pdsb), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer and infectious disease, today announced that the company will release financial results for the first quarter of 2023 on monday, may 15, 2023, before the market opens. following the release, management will host a conference call to review the financial results and provide a business update.
PDSB Ratings Summary
PDSB Quant Ranking